News
The pharmaceutical and biotech sectors suffer more data security breaches than any other industry, with 53% resulting from malicious activity. To protect against potential cyber attacks, organizations must implement an effective strategy that allows for proactive detection and rapid response.
In this GEN article, Rob Scoffin and Iain Ronayne discuss strategies for assuring and future-proofing data security for safe and efficient drug discovery.
Read the full article, 'Future-proofing Cybersecurity in Drug Discovery' as published in Genetic Engineering & Biotechnology News.
Abstract Pyrethroids are a common class of pesticide which are used in crop and personal protection against insects. The insecticidal ...
Neurogenerative diseases are often characterized by the formation of insoluble protein aggregates from amyloidogenic proteins. Alzheimer’s disease, currently the most ...
In their recent article in Journal of Medicinal Chemistry, Stuart Lang and Martin Slater review in silico approaches for identifying ...